Clinical Trial Update: Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating esketamine for chronic pain due to endometriosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Pelvic Pain Syndrome

Drugs mentioned

• Spravato (esketamine) (esketamine)

Snippet

Sponsor: Reinier de Graaf Groep | Conditions: Endometriosis, Chronic Pelvic Pain Syndrome | Phase 3 | Status: RECRUITING